Literature DB >> 19067416

Hospitalizations for inflammatory bowel disease: profile of the uninsured in the United States.

Geoffrey C Nguyen1, Justina Sam, Sanjay K Murthy, Gilaad G Kaplan, Jill M Tinmouth, Thomas A LaVeist.   

Abstract

BACKGROUND: Inflammatory bowel disease (IBD) patients may be at increased risk for having no health insurance. Our objectives were to assess the prevalence of hospitalized IBD patients without insurance in the US and to characterize predictive factors.
METHODS: We identified IBD admissions in the Nationwide Inpatient Sample (1999-2005) and a 1% sample of general medical patients. We used population estimates from the US Census Bureau to calculate hospitalization rates, and logistic regression to determine predictors of being uninsured.
RESULTS: Although uninsured IBD patients were less likely to be hospitalized than those privately insured (incidence rate ratio [IRR] 0.41; 95% confidence interval [CI]: 0.38-0.45), their hospitalization rate increased from 8.3/100,000 to 12.5/100,000 (P < 0.001) over 7 years, outpacing private admissions. The proportion of uninsured IBD inpatients increased from 4.6% to 6.5% (P < 0.001), and IBD patients were more likely than general medical patients to be uninsured (5.1% vs. 4.1%, P < 0.0001). Predictors of being uninsured were being 21 to 40 years (odds ratio [OR] 1.95; 95% CI: 1.64-2.31), African American (OR 1.51; 95% CI: 1.29-0.76) or Hispanic (OR 2.21; 95% CI: 1.79-2.74), or residing in the southern US (OR 1.63; 95% CI: 1.27-2.11). Being female (OR 0.65; 95% CI: 0.61-0.70), residing in higher income neighborhoods (OR 0.69; 95% CI: 0.62-0.77), and higher comorbidity were protective factors.
CONCLUSIONS: The rate of uninsured IBD admissions has risen disproportionately relative to the privately insured and general medical populations. We need measures to alleviate the burden of being uninsured among young and otherwise healthy adults with IBD who are most vulnerable.

Entities:  

Mesh:

Year:  2009        PMID: 19067416     DOI: 10.1002/ibd.20825

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  7 in total

Review 1.  Systematic review: The role of race and socioeconomic factors on IBD healthcare delivery and effectiveness.

Authors:  Justin L Sewell; Fernando S Velayos
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

2.  Radiation exposure from diagnostic imaging studies among patients with inflammatory bowel disease in a safety-net health-care system.

Authors:  Jason K Hou; Hoda M Malaty; Selvi Thirumurthi
Journal:  Dig Dis Sci       Date:  2013-09-12       Impact factor: 3.199

3.  Ethical considerations for clinical trials in inflammatory bowel disease.

Authors:  David T Rubin; Samuel Becker; Mark Siegler
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-01

4.  Black and White Patients With Inflammatory Bowel Disease Show Similar Biologic Use Patterns With Medicaid Insurance.

Authors:  Edward L Barnes; Christina M Bauer; Robert S Sandler; Michael D Kappelman; Millie D Long
Journal:  Inflamm Bowel Dis       Date:  2021-02-16       Impact factor: 5.325

5.  13-year mortality trends among hospitalized patients with inflammatory bowel disease.

Authors:  Justin L Sewell; Hal F Yee
Journal:  BMC Gastroenterol       Date:  2012-06-26       Impact factor: 3.067

Review 6.  AGA Technical Review on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.

Authors:  Siddharth Singh; Deborah Proctor; Frank I Scott; Yngve Falck-Ytter; Joseph D Feuerstein
Journal:  Gastroenterology       Date:  2021-06       Impact factor: 33.883

7.  Minority Pediatric Patients with Inflammatory Bowel Disease Demonstrate an Increased Length of Stay.

Authors:  Edward L Barnes; Bharati Kochar; Millie D Long; Christopher F Martin; Michael D Kappelman
Journal:  Inflamm Bowel Dis       Date:  2017-12       Impact factor: 7.290

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.